MORGAN ROBERTS: Open Payments
NPI 1598444283 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $65 |
| Biogen, Inc. | 3 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| Dexcom, Inc. | 1 | $27 |
| Organon LLC | 1 | $23 |
| Exeltis, USA Inc. | 1 | $21 |
| CooperSurgical, Inc. | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: Veozah, ZURZUVAE, Dexcom G6 Transmitter, NEXPLANON, SLYND, Paragard T 380A, ZEPBOUND, Prograf.
Industry payments across NE — which companies pay providers there.
